TMEM9 was found to be abnormally expressed in liver cancers (Zhang et al., 2016), and it was described as an oncogene implicated in tumour development, invasion, and chemoresistance (Schmit and Michiels, 2018). Here, TMEM9 is linked to neoplasm.